关键词: 抗肿瘤药物, 皮下制剂, 全程管理, 平台

Abstract: Objective: To develop a patient-centric management platform for anti-tumor subcutaneous preparations and verify its clinical practice effectiveness. Methods: Based on the "user experience element model", a full process management platform system architecture was designed and platform module content in combination with patient needs was constructed. Patients receiving anti-tumor subcutaneous injection who visited a grade A tertiary hospital in Tianjin were inlcuded from January 2024 to July 2024 by conveniently sampling. They were randomly divided into a control group (75 cases) and an intervention group (75 cases). The control group received routine management and WeChat follow-up, while the intervention group received full management through the platform. The self-efficacy and quality of life were compared between two groups. Results: After one month of intervention, the self-efficacy and quality of life scores of the intervention group were higher than those of the control group, and the difference was statistically significant (P<0.05). Conclusion: The whole process management platform for anti-tumor subcutaneous preparations can improve patients′ self -efficacy and quality of life, meet their needs for diagnosis and treatment throughout the process. It can provide effective reference for clinical management practice.

Key words: Anti-tumor drugs, Subcutaneous preparations, Full process management, Platform